Machine learning applications for therapeutic tasks with genomics data
暂无分享,去创建一个
Jimeng Sun | Cao Xiao | Lucas M. Glass | Greg Gibson | Kexin Huang | Cathy W. Critchlow | Jimeng Sun | G. Gibson | Cao Xiao | Lucas Glass | C. Critchlow | Kexin Huang
[1] Max Welling,et al. Semi-Supervised Classification with Graph Convolutional Networks , 2016, ICLR.
[2] Harlan M Krumholz,et al. Participation in cancer clinical trials: race-, sex-, and age-based disparities. , 2004, JAMA.
[3] Srinivas Aluru,et al. GRNUlar: Gene Regulatory Network reconstruction using Unrolled algorithm from Single Cell RNA-Sequencing data , 2020, bioRxiv.
[4] Jimeng Sun,et al. MolTrans: Molecular Interaction Transformer for drug–target interaction prediction , 2020, Bioinform..
[5] Wen-Lian Hsu,et al. NERBio: using selected word conjunctions, term normalization, and global patterns to improve biomedical named entity recognition , 2006, BMC Bioinformatics.
[6] Julio Licinio,et al. From monoamines to genomic targets: a paradigm shift for drug discovery in depression , 2004, Nature Reviews Drug Discovery.
[7] K-R Müller,et al. SchNet - A deep learning architecture for molecules and materials. , 2017, The Journal of chemical physics.
[8] Ruibang Luo,et al. A multi-task convolutional deep neural network for variant calling in single molecule sequencing , 2019, Nature Communications.
[9] Joshua J. Levy,et al. MethylNet: an automated and modular deep learning approach for DNA methylation analysis , 2020, BMC Bioinformatics.
[10] Eric D. Kelsic,et al. Challenges and opportunities of machine-guided capsid engineering for gene therapy , 2019, Cell and Gene Therapy Insights.
[11] S. Ebrahim,et al. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.
[12] P. Vickers,et al. Challenges and opportunities in the treatment of rare diseases , 2013 .
[13] Ping Luo,et al. Enhancing the prediction of disease-gene associations with multimodal deep learning , 2019, Bioinform..
[14] M. Huss,et al. A primer on deep learning in genomics , 2018, Nature Genetics.
[15] Ash A. Alizadeh,et al. Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.
[16] R. Guigó,et al. Are splicing mutations the most frequent cause of hereditary disease? , 2005, FEBS letters.
[17] G. Church,et al. Unraveling CRISPR-Cas9 genome engineering parameters via a library-on-library approach , 2015, Nature Methods.
[18] Xiao-Hui Zhang,et al. Off-target Effects in CRISPR/Cas9-mediated Genome Engineering , 2015, Molecular therapy. Nucleic acids.
[19] B. Frey,et al. Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning , 2015, Nature Biotechnology.
[20] Patrik L. Ståhl,et al. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics , 2016, Science.
[21] Alexander A. Morgan,et al. Rutabaga by any other name: extracting biological names , 2002, J. Biomed. Informatics.
[22] Jimeng Sun,et al. Therapeutics Data Commons: Machine Learning Datasets and Tasks for Therapeutics , 2021, ArXiv.
[23] Douglas A Lauffenburger,et al. Computational translation of genomic responses from experimental model systems to humans , 2019, PLoS Comput. Biol..
[24] Noel E. O'Connor,et al. Unsupervised label noise modeling and loss correction , 2019, ICML.
[25] L. Ungar,et al. MediBoost: a Patient Stratification Tool for Interpretable Decision Making in the Era of Precision Medicine , 2016, Scientific Reports.
[26] Yves Moreau,et al. GRNBoost2 and Arboreto: efficient and scalable inference of gene regulatory networks , 2018, Bioinform..
[27] A. Aliper,et al. In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development , 2016, Nature Communications.
[28] Fangfang Xia,et al. Predicting tumor cell line response to drug pairs with deep learning , 2018, BMC Bioinformatics.
[29] Fabian J Theis,et al. Deep learning: new computational modelling techniques for genomics , 2019, Nature Reviews Genetics.
[30] Tom R. Gaunt,et al. Exploiting horizontal pleiotropy to search for causal pathways within a Mendelian randomization framework , 2020, Nature Communications.
[31] Jure Leskovec,et al. Strategies for Pre-training Graph Neural Networks , 2020, ICLR.
[32] Lucy J. Colwell,et al. Deep diversification of an AAV capsid protein by machine learning , 2021, Nature Biotechnology.
[33] Abdelaali Hassaine,et al. Untangling the complexity of multimorbidity with machine learning , 2020, Mechanisms of Ageing and Development.
[34] Olaf Wolkenhauer,et al. LoRAS: an oversampling approach for imbalanced datasets , 2019, Machine Learning.
[35] Roded Sharan,et al. Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients , 2021, Nature Cancer.
[36] Base-resolution models of transcription factor binding reveal soft motif syntax , 2021, Nature genetics.
[37] Bronwen L. Aken,et al. GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.
[38] Jennifer F. Hughes,et al. Conservation, acquisition, and functional impact of sex-biased gene expression in mammals , 2019, Science.
[39] Denis C. Bauer,et al. High Activity Target-Site Identification Using Phenotypic Independent CRISPR-Cas9 Core Functionality. , 2018, The CRISPR journal.
[40] Roded Sharan,et al. Using deep learning to model the hierarchical structure and function of a cell , 2018, Nature Methods.
[41] Hongbin Zhong,et al. Systematic comparison of germline variant calling pipelines cross multiple next-generation sequencers , 2019, Scientific Reports.
[42] F. Collins,et al. The path to personalized medicine. , 2010, The New England journal of medicine.
[43] J. Millán,et al. Gene Therapy Using Adeno‐Associated Virus Serotype 8 Encoding TNAP‐D10 Improves the Skeletal and Dentoalveolar Phenotypes in Alpl −/− Mice , 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[44] Le Yang,et al. Deep-learning approach to identifying cancer subtypes using high-dimensional genomic data , 2019, Bioinform..
[45] Z. Werb,et al. Tumors as organs: complex tissues that interface with the entire organism. , 2010, Developmental cell.
[46] De-Shuang Huang,et al. High-Order Convolutional Neural Network Architecture for Predicting DNA-Protein Binding Sites , 2019, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[47] Jeremy B. R. Hayter,et al. Utilising Graph Machine Learning within Drug Discovery and Development , 2020, ArXiv.
[48] Haibo He,et al. ADASYN: Adaptive synthetic sampling approach for imbalanced learning , 2008, 2008 IEEE International Joint Conference on Neural Networks (IEEE World Congress on Computational Intelligence).
[49] Jari Björne,et al. BioInfer: a corpus for information extraction in the biomedical domain , 2007, BMC Bioinformatics.
[50] Jure Leskovec,et al. GNNExplainer: Generating Explanations for Graph Neural Networks , 2019, NeurIPS.
[51] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[52] J. Marioni,et al. Computational principles and challenges in single-cell data integration , 2021, Nature Biotechnology.
[53] B. Neale,et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases , 2018, Nature Genetics.
[54] Matthew Willetts,et al. Statistical machine learning of sleep and physical activity phenotypes from sensor data in 96,220 UK Biobank participants , 2017, Scientific Reports.
[55] Jianxin Chen,et al. Large-scale exploration and analysis of drug combinations , 2015, Bioinform..
[56] Q. Zou,et al. Gene2vec: gene subsequence embedding for prediction of mammalian N6-methyladenosine sites from mRNA , 2018, RNA.
[57] Jure Leskovec,et al. MARS: discovering novel cell types across heterogeneous single-cell experiments. , 2020, Nature methods.
[58] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[59] Jimeng Sun,et al. CONAN: Complementary Pattern Augmentation for Rare Disease Detection , 2019, AAAI.
[60] Jin-Soo Kim,et al. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases , 2014, Bioinform..
[61] Yoshua Bengio,et al. Diet Networks: Thin Parameters for Fat Genomic , 2016, ICLR.
[62] Ke Wang,et al. A high-throughput SNP discovery strategy for RNA-seq data , 2019, BMC Genomics.
[63] Demis Hassabis,et al. Improved protein structure prediction using potentials from deep learning , 2020, Nature.
[64] Erhan Bilal,et al. Understanding the limits of animal models as predictors of human biology: lessons learned from the sbv IMPROVER Species Translation Challenge , 2014, Bioinform..
[65] E. Pierson,et al. An algorithmic approach to reducing unexplained pain disparities in underserved populations , 2021, Nature Medicine.
[66] Gill Bejerano,et al. A sequence-based, deep learning model accurately predicts RNA splicing branchpoints , 2017, bioRxiv.
[67] Sergey Levine,et al. Model-Agnostic Meta-Learning for Fast Adaptation of Deep Networks , 2017, ICML.
[68] Richard S. Zemel,et al. Prototypical Networks for Few-shot Learning , 2017, NIPS.
[69] Chloé-Agathe Azencott,et al. Machine learning and genomics: precision medicine versus patient privacy , 2018, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[70] Jimeng Sun,et al. Highly elevated polygenic risk scores are better predictors of myocardial infarction risk early in life than later , 2021, Genome medicine.
[71] Rajesh Ranganath,et al. ClinicalBERT: Modeling Clinical Notes and Predicting Hospital Readmission , 2019, ArXiv.
[72] K. Robertson. DNA methylation and human disease , 2005, Nature Reviews Genetics.
[73] Raymond Fok,et al. Does the Whole Exceed its Parts? The Effect of AI Explanations on Complementary Team Performance , 2020, CHI.
[74] Jimeng Sun,et al. COMPOSE: Cross-Modal Pseudo-Siamese Network for Patient Trial Matching , 2020, KDD.
[75] Brendan J. Frey,et al. Machine Learning in Genomic Medicine: A Review of Computational Problems and Data Sets , 2016, Proceedings of the IEEE.
[76] Ruibang Luo,et al. Exploring the limit of using a deep neural network on pileup data for germline variant calling , 2020, Nature Machine Intelligence.
[77] M. Wittrock. Learning as a Generative Process , 1974 .
[78] Luca Oneto,et al. Fairness in Machine Learning , 2020, INNSBDDL.
[79] Joshua J. Levy,et al. PyMethylProcess - convenient high-throughput preprocessing workflow for DNA methylation data , 2019, Bioinform..
[80] Chunlin Xiao,et al. An open resource for accurately benchmarking small variant and reference calls , 2019, Nature Biotechnology.
[81] Thawfeek M. Varusai,et al. The Reactome Pathway Knowledgebase , 2017, Nucleic acids research.
[82] M. Kramer. Nonlinear principal component analysis using autoassociative neural networks , 1991 .
[83] Olga G Troyanskaya,et al. An integrative tissue-network approach to identify and test human disease genes , 2018, Nature Biotechnology.
[84] Andrew M. Gross,et al. Network-based stratification of tumor mutations , 2013, Nature Methods.
[85] Zhao Li,et al. Anticancer drug synergy prediction in understudied tissues using transfer learning , 2020, J. Am. Medical Informatics Assoc..
[86] Francisco Herrera,et al. A unifying view on dataset shift in classification , 2012, Pattern Recognit..
[87] Juan J Cáceres,et al. Disease gene prediction for molecularly uncharacterized diseases , 2019, PLoS Comput. Biol..
[88] C. Skinner,et al. Conceptual Model for Accrual to Cancer Clinical Trials. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[89] J. Keith Joung,et al. High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.
[90] Sungroh Yoon,et al. Deep learning improves prediction of CRISPR–Cpf1 guide RNA activity , 2018, Nature Biotechnology.
[91] Jacqueline Corrigan-Curay,et al. Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness. , 2018, JAMA.
[92] G. de los Campos,et al. Can Deep Learning Improve Genomic Prediction of Complex Human Traits? , 2018, Genetics.
[93] Christopher Y. Park,et al. Whole-genome deep-learning analysis identifies contribution of noncoding mutations to autism risk , 2019, Nature Genetics.
[94] Gill Bejerano,et al. S-CAP extends pathogenicity prediction to genetic variants that affect RNA splicing , 2019, Nature Genetics.
[95] Jimeng Sun,et al. DeepEnroll: Patient-Trial Matching with Deep Embedding and Entailment Prediction , 2020, WWW.
[96] M. Ghert,et al. Lost in translation: animal models and clinical trials in cancer treatment. , 2014, American journal of translational research.
[97] Tom R. Gaunt,et al. Automating Mendelian randomization through machine learning to construct a putative causal map of the human phenome , 2017, bioRxiv.
[98] Kok Siong Ang,et al. A benchmark of batch-effect correction methods for single-cell RNA sequencing data , 2020, Genome Biology.
[99] Jure Leskovec,et al. Handling Missing Data with Graph Representation Learning , 2020, NeurIPS.
[100] Geoffrey E. Hinton,et al. ImageNet classification with deep convolutional neural networks , 2012, Commun. ACM.
[101] Peter Szolovits,et al. What’s in a Note? Unpacking Predictive Value in Clinical Note Representations , 2018, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.
[102] Emma J. Chory,et al. A Deep Learning Approach to Antibiotic Discovery , 2020, Cell.
[103] R. Wall,et al. A mechanism for RNA splicing. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[104] Xiaohui Xie,et al. DANN: a deep learning approach for annotating the pathogenicity of genetic variants , 2015, Bioinform..
[105] Eli J. Fine,et al. DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.
[106] Ludvig Bergenstråhle,et al. Integrating spatial gene expression and breast tumour morphology via deep learning , 2020, Nature Biomedical Engineering.
[107] Deanna M. Church,et al. ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..
[108] A. Schambach,et al. Hematopoietic stem-cell senescence and myocardial repair - Coronary artery disease genotype/phenotype analysis of post-MI myocardial regeneration response induced by CABG/CD133+ bone marrow hematopoietic stem cell treatment in RCT PERFECT Phase 3 , 2020, EBioMedicine.
[109] P. Geurts,et al. Inferring Regulatory Networks from Expression Data Using Tree-Based Methods , 2010, PloS one.
[110] José Alquicira-Hernandez,et al. Benchmarking of cell type deconvolution pipelines for transcriptomics data , 2020, Nature Communications.
[111] Paul M. Thompson,et al. Brain Imaging Genomics: Integrated Analysis and Machine Learning , 2020, Proceedings of the IEEE.
[112] K. Rawlik,et al. An atlas of genetic associations in UK Biobank , 2017, Nature Genetics.
[113] Yuan Gao,et al. Improving molecular cancer class discovery through sparse non-negative matrix factorization , 2005 .
[114] Feng Liu,et al. PEDLA: predicting enhancers with a deep learning-based algorithmic framework , 2016, Scientific Reports.
[115] J. Kent,et al. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR , 2016, Genome Biology.
[116] David Lopez-Paz,et al. Invariant Risk Minimization , 2019, ArXiv.
[117] Pooja Mittal,et al. A novel signaling pathway impact analysis , 2009, Bioinform..
[118] Demis Hassabis,et al. Mastering the game of Go with deep neural networks and tree search , 2016, Nature.
[119] Nuno A. Fonseca,et al. Pathway and network analysis of more than 2500 whole cancer genomes , 2020, Nature Communications.
[120] T. Spector,et al. Predicting genome-wide DNA methylation using methylation marks, genomic position, and DNA regulatory elements , 2013, Genome Biology.
[121] Hua Xu,et al. Predict effective drug combination by deep belief network and ontology fingerprints , 2018, J. Biomed. Informatics.
[122] Peter Minary,et al. crisprSQL: a novel database platform for CRISPR/Cas off-target cleavage assays , 2020, Nucleic Acids Res..
[123] Howard Y. Chang,et al. Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.
[124] Thomas G. Dietterich. What is machine learning? , 2020, Archives of Disease in Childhood.
[125] Pascal Vincent,et al. Stacked Denoising Autoencoders: Learning Useful Representations in a Deep Network with a Local Denoising Criterion , 2010, J. Mach. Learn. Res..
[126] W. Hahn,et al. Biologically informed deep neural network for prostate cancer classification and discovery , 2020, bioRxiv.
[127] Avanti Shrikumar,et al. Base-resolution models of transcription factor binding reveal soft motif syntax , 2019, Nature Genetics.
[128] Tom Sercu,et al. Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences , 2021, Proceedings of the National Academy of Sciences.
[129] Jean-Philippe Vert,et al. TIGRESS: Trustful Inference of Gene REgulation using Stability Selection , 2012, BMC Systems Biology.
[130] Wei Zheng,et al. Drug–drug interaction extraction via hierarchical RNNs on sequence and shortest dependency paths , 2017, Bioinform..
[131] Allison P. Heath,et al. The NCI Genomic Data Commons , 2021, Nature Genetics.
[132] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[133] David K. Gifford,et al. Convolutional neural network architectures for predicting DNA–protein binding , 2016, Bioinform..
[134] Ming-Wei Chang,et al. BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding , 2019, NAACL.
[135] Zhuowen Tu,et al. Similarity network fusion for aggregating data types on a genomic scale , 2014, Nature Methods.
[136] Charles E. Vejnar,et al. CRISPRscan: designing highly efficient sgRNAs for CRISPR/Cas9 targeting in vivo , 2015, Nature Methods.
[137] O. Delaneau,et al. Supplementary Information for ‘ Improved whole chromosome phasing for disease and population genetic studies ’ , 2012 .
[138] Ka-Chun Wong,et al. Off-target predictions in CRISPR-Cas9 gene editing using deep learning , 2018, Bioinform..
[139] Sijian Wang,et al. SPARSE INTEGRATIVE CLUSTERING OF MULTIPLE OMICS DATA SETS. , 2013, The annals of applied statistics.
[140] Guido Sanguinetti,et al. Melissa: Bayesian clustering and imputation of single-cell methylomes , 2019, Genome Biology.
[141] Yan Liu,et al. Recurrent Neural Networks for Multivariate Time Series with Missing Values , 2016, Scientific Reports.
[142] Wei Wang,et al. Predicting the Human Epigenome from DNA Motifs , 2014, Nature Methods.
[143] Mark R. Trusheim,et al. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers , 2007, Nature Reviews Drug Discovery.
[144] Benjamin Haibe-Kains,et al. Dr.VAE: improving drug response prediction via modeling of drug perturbation effects , 2019, Bioinform..
[145] Peng Qiu,et al. COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites , 2014, Molecular therapy. Nucleic acids.
[146] Marie-Francine Moens,et al. A survey on the application of recurrent neural networks to statistical language modeling , 2015, Comput. Speech Lang..
[147] Yoshua Bengio,et al. On the Properties of Neural Machine Translation: Encoder–Decoder Approaches , 2014, SSST@EMNLP.
[148] Andreas Bender,et al. DeepSynergy: predicting anti-cancer drug synergy with Deep Learning , 2017, Bioinform..
[149] Yoseph Barash,et al. Integrative deep models for alternative splicing , 2017, bioRxiv.
[150] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[151] Kexin Huang,et al. An Interpretable End-to-end Fine-tuning Approach for Long Clinical Text , 2020, ArXiv.
[152] Lukasz Kaiser,et al. Reformer: The Efficient Transformer , 2020, ICLR.
[153] Núria Queralt-Rosinach,et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..
[154] Amir K. Foroushani,et al. Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen , 2019, Nature Communications.
[155] Atul J. Butte,et al. Systematic survey reveals general applicability of "guilt-by-association" within gene coexpression networks , 2005, BMC Bioinformatics.
[156] Lukasz Kaiser,et al. Attention is All you Need , 2017, NIPS.
[157] Stan J. J. Brouns,et al. Evolution and classification of the CRISPR–Cas systems , 2011, Nature Reviews Microbiology.
[158] Stef van Buuren,et al. Flexible Imputation of Missing Data , 2012 .
[159] K. Propert,et al. Immune responses to adenovirus and adeno-associated virus in humans , 1999, Gene Therapy.
[160] A. Khera,et al. Mendelian Randomization. , 2017, JAMA.
[161] Mehmet Tan,et al. Drug response prediction by ensemble learning and drug-induced gene expression signatures , 2018, Genomics.
[162] Nigel Collier,et al. Learning Orthographic Features in Bi-directional LSTM for Biomedical Named Entity Recognition , 2016, BioTxtM@COLING 2016.
[163] O. Stegle,et al. DeepCpG: accurate prediction of single-cell DNA methylation states using deep learning , 2016, Genome Biology.
[164] Thomas C. Wiegers,et al. A CTD–Pfizer collaboration: manual curation of 88 000 scientific articles text mined for drug–disease and drug–phenotype interactions , 2013, Database J. Biol. Databases Curation.
[165] E. Scarano,et al. DNA Methylation , 1973, Nature.
[166] Max Welling,et al. Auto-Encoding Variational Bayes , 2013, ICLR.
[167] M. Boutros,et al. E-CRISP: fast CRISPR target site identification , 2014, Nature Methods.
[168] M. Boguski,et al. Functional genomics: it's all how you read it. , 1997, Science.
[169] Stefan Bonn,et al. Deep learning–based cell composition analysis from tissue expression profiles , 2020, Science Advances.
[170] M. Snyder,et al. High-throughput sequencing technologies. , 2015, Molecular cell.
[171] Jimeng Sun,et al. CORE: Automatic Molecule Optimization Using Copy & Refine Strategy , 2019, AAAI.
[172] Chandra L. Theesfeld,et al. Deep learning sequence-based ab initio prediction of variant effects on expression and disease risk , 2018, Nature Genetics.
[173] Bo Wang,et al. Machine Learning for Integrating Data in Biology and Medicine: Principles, Practice, and Opportunities , 2018, Inf. Fusion.
[174] Guohui Chuai,et al. DeepCRISPR: optimized CRISPR guide RNA design by deep learning , 2018, Genome Biology.
[175] Jason A. Papin,et al. Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions , 2017, Nature Communications.
[176] Nitesh V. Chawla,et al. SMOTE: Synthetic Minority Over-sampling Technique , 2002, J. Artif. Intell. Res..
[177] Jürgen Schmidhuber,et al. Long Short-Term Memory , 1997, Neural Computation.
[178] Casey S Greene,et al. MultiPLIER: A Transfer Learning Framework for Transcriptomics Reveals Systemic Features of Rare Disease. , 2019, Cell systems.
[179] Wei Q. Deng,et al. A machine-learning heuristic to improve gene score prediction of polygenic traits , 2017, Scientific Reports.
[180] O. Troyanskaya,et al. Predicting effects of noncoding variants with deep learning–based sequence model , 2015, Nature Methods.
[181] Paul M. Thompson,et al. Proceedings of the Fifth Workshop on Building and Evaluating Resources for Biomedical Text Mining (BioTxtM2016) , 2016 .
[182] Sridhar Ramaswamy,et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..
[183] Valerie Obenchain,et al. Risk prediction using genome‐wide association studies , 2010, Genetic epidemiology.
[184] Scott D Ramsey,et al. A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. , 2010, Journal of the National Cancer Institute.
[185] Mike Tyers,et al. Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. , 2015, Cell systems.
[186] Ryan T. Leenay,et al. Large dataset enables prediction of repair after CRISPR–Cas9 editing in primary T cells , 2019, Nature Biotechnology.
[187] Regina Barzilay,et al. Junction Tree Variational Autoencoder for Molecular Graph Generation , 2018, ICML.
[188] Tero Aittokallio,et al. Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorization , 2016, Bioinform..
[189] Xiaoping Li,et al. A Survey on Sparse Learning Models for Feature Selection , 2020, IEEE Transactions on Cybernetics.
[190] Alicia R. Martin,et al. Hidden ‘risk’ in polygenic scores: clinical use today could exacerbate health disparities , 2018, bioRxiv.
[191] P. Robinson,et al. Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.
[192] Dexter Hadley,et al. Systematic integration of biomedical knowledge prioritizes drugs for repurposing , 2017, bioRxiv.
[193] Mei Wang,et al. Deep Visual Domain Adaptation: A Survey , 2018, Neurocomputing.
[194] Zhong Ren,et al. Annotating pathogenic non-coding variants in genic regions , 2017, Nature Communications.
[195] Thomas Colthurst,et al. A universal SNP and small-indel variant caller using deep neural networks , 2018, Nature Biotechnology.
[196] K. Williams,et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. , 2012, Journal of the American College of Cardiology.
[197] Jun Wang,et al. Predicting Anticancer Drug Responses Using a Dual-Layer Integrated Cell Line-Drug Network Model , 2015, PLoS Comput. Biol..
[198] Kenneth I. Berns,et al. Gene Therapy Using Adeno-Associated Virus Vectors , 2008, Clinical Microbiology Reviews.
[200] Hongfei Lin,et al. Drug drug interaction extraction from biomedical literature using syntax convolutional neural network , 2016, Bioinform..
[201] Jianzhu Ma,et al. Predicting Drug Response and Synergy Using a Deep Learning Model of Human Cancer Cells. , 2020, Cancer cell.
[202] Tero Aittokallio,et al. Machine learning and feature selection for drug response prediction in precision oncology applications , 2018, Biophysical Reviews.
[203] Zhen Cao,et al. Simple tricks of convolutional neural network architectures improve DNA-protein binding prediction , 2018, Bioinform..
[204] Yves Moreau,et al. Candidate gene prioritization with Endeavour , 2016, Nucleic Acids Res..
[205] Aaron C. Courville,et al. Generative adversarial networks , 2020 .
[206] Francisco Avila Cobos,et al. Computational deconvolution of transcriptomics data from mixed cell populations , 2018, Bioinform..
[207] Yijia Zhang,et al. A hybrid model based on neural networks for biomedical relation extraction , 2018, J. Biomed. Informatics.
[208] Benjamin S. Glicksberg,et al. Identification of type 2 diabetes subgroups through topological analysis of patient similarity , 2015, Science Translational Medicine.
[209] Robert Tibshirani,et al. A Framework for Feature Selection in Clustering , 2010, Journal of the American Statistical Association.
[210] B. Frey,et al. The human splicing code reveals new insights into the genetic determinants of disease , 2015, Science.
[211] Jennifer Listgarten,et al. Prediction of off-target activities for the end-to-end design of CRISPR guide RNAs , 2018, Nature Biomedical Engineering.
[212] Joseph Bergenstråhle,et al. Single-cell and spatial transcriptomics enables probabilistic inference of cell type topography , 2020, Communications Biology.
[213] Joseph Bergenstråhle,et al. Super-resolved spatial transcriptomics by deep data fusion , 2020, Nature Biotechnology.
[214] J. L. Mateo,et al. Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications , 2017, Nucleic acids research.
[215] Jonathan R. Karr,et al. A Whole-Cell Computational Model Predicts Phenotype from Genotype , 2012, Cell.
[216] Z. Yakhini,et al. Spatial transcriptomics inferred from pathology whole-slide images links tumor heterogeneity to survival in breast and lung cancer , 2020, Scientific reports.
[217] Lei Deng,et al. DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy , 2019, Nucleic Acids Res..
[218] Kristopher T. Jensen,et al. Chromatin accessibility and guide sequence secondary structure affect CRISPR‐Cas9 gene editing efficiency , 2017, FEBS letters.
[219] Qiang Yang,et al. Federated Machine Learning , 2019, ACM Trans. Intell. Syst. Technol..
[220] Umit Topaloglu,et al. Natural language processing and recurrent network models for identifying genomic mutation-associated cancer treatment change from patient progress notes , 2019, JAMIA open.
[221] S. Waqar Jaffry,et al. Information extraction from scientific articles: a survey , 2018, Scientometrics.
[222] David R. Kelley,et al. Basset: learning the regulatory code of the accessible genome with deep convolutional neural networks , 2015, bioRxiv.
[223] Jannik N. Andersen,et al. Cancer genomics: from discovery science to personalized medicine , 2011, Nature Medicine.
[224] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[225] F. Markowetz,et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.
[226] Renaud Gaujoux,et al. Found In Translation: a machine learning model for mouse-to-human inference , 2018, Nature Methods.
[227] Alexander Schönhuth,et al. Using the structure of genome data in the design of deep neural networks for predicting amyotrophic lateral sclerosis from genotype , 2019, Bioinform..
[228] O. Stegle,et al. Deep learning for computational biology , 2016, Molecular systems biology.
[229] Francisco M. Couto,et al. Extracting microRNA-gene relations from biomedical literature using distant supervision , 2017, PloS one.
[230] Theodore Sakellaropoulos,et al. The species translation challenge—A systems biology perspective on human and rat bronchial epithelial cells , 2014, Scientific Data.
[231] Brian Hie,et al. Leveraging Uncertainty in Machine Learning Accelerates Biological Discovery and Design. , 2020, Cell systems.
[232] Alexander Tuzhilin,et al. The long tail of recommender systems and how to leverage it , 2008, RecSys '08.
[233] Antonio Pertusa,et al. Learning Eligibility in Cancer Clinical Trials using Deep Neural Networks , 2018, Applied Sciences.
[234] Christopher D. Manning,et al. Graph Convolution over Pruned Dependency Trees Improves Relation Extraction , 2018, EMNLP.
[235] Jing Su,et al. DSTG: deconvoluting spatial transcriptomics data through graph-based artificial intelligence , 2020, bioRxiv.
[236] Frank Rosenblatt,et al. PRINCIPLES OF NEURODYNAMICS. PERCEPTRONS AND THE THEORY OF BRAIN MECHANISMS , 1963 .
[237] Klaus-Robert Müller,et al. Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases , 2019, Science Translational Medicine.
[238] Yoshua Bengio,et al. Convolutional networks for images, speech, and time series , 1998 .
[239] Xiaolin Li,et al. GRAM-CNN: a deep learning approach with local context for named entity recognition in biomedical text , 2017, Bioinform..